Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
JULY 1, 2022
Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved Drugs. Fixing The FDA’s Orange Book. Coverage of New Drugs in Medicare Part D. J Am Pharm Assoc (2003). A full posting of abstracts/summaries of these articles may be found on our? Health Aff (Millwood). 2022 May 3.
Let's personalize your content